TCTR20190111001.

Trial name or title	Assessment of efficacy of anthelmintic drugs against soil‐transmitted helminths in Thailand
Methods	Randomized trial (TCTR20190111001)
Participants	Number of participants: 252 Inclusion criteria Age: 18–70 years Infected with any of Ascaris, hookworms, Trichuris, or Strongyloides) Exclusion criteria History of acute or severe chronic Pregnant or lactating Vomited within 4 hours after drug administration Unable to provide a stool sample at follow‐up History of allergic reaction to albendazole, mebendazole, or ivermectin
Interventions	Group 1: albendazole 400 mg single dose Group 2: albendazole 400 mg twice daily for 3 days Group 3: ivermectin 200 μg/kg single dose Group 4: mebendazole 100 mg twice daily for 3 days Group 5: albendazole 400 mg single dose + ivermectin 200 μg/kg single dose Group 6: mebendazole 500 mg single dose + ivermectin 200 μg/kg single dose
Outcomes	Cure rate 3 weeks after treatment Egg reduction rate Modified Kato‐Katz thick smear, Harada‐mori
Starting date	Not reported
Contact information	Vivornpun Sanprasert Department of Parasitology, Faculty of Medicine, Chulalongkorn University 1873 Rama IV Road, Pathumwa, Bangkok 10330, Thailand
Notes	Funding: Department of Parasitology, Faculty of Medicine, Chulalongkorn University 1873 Rama IV Road, Pathumwa, Bangkok, 10330, Thailand +6622564387 17; vivornpun@chula.md